Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient

被引：14
|
作者：
Engelhardt, M
Müller, AMS
Maier, W
Wäsch, R
机构：
[1] Univ Med Ctr, Dept Hematol & Oncol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Otolaryngol, D-7800 Freiburg, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 05期
关键词：
D O I：
10.1038/sj.leu.2403723
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：869 / 870
页数：2
相关论文
共 50 条
  • [21] Combination therapy with velcade, doxil, and dexamethasone (VDD) for patients with relapsed/refractory multiple myeloma (MM).
    Jakubowiak, AJ
    Brackett, L
    Kendall, T
    Friedman, J
    Kaminski, MS
    BLOOD, 2005, 106 (11) : 378B - 378B
  • [22] Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy
    Kuroda, Junya
    Mizutani, Shinsuke
    Shimura, Yuji
    Maegawa, Saori
    Nagoshi, Hisao
    Chinen, Yoshiaki
    Tatekawa, Shotaro
    Tsukamoto, Taku
    Mizuno, Yoshimi
    Yamamoto-Sugitani, Mio
    Kobayashi, Tsutomu
    Matsumoto, Yosuke
    Horiike, Shigeo
    Taniwaki, Masafumi
    ANNALS OF HEMATOLOGY, 2015, 94 (04) : 687 - 689
  • [23] Neurotoxicity of bortezomib therapy in multiple myeloma (MM): A single center experience.
    Badros, Ashraf
    Dalal, Jay S.
    Goloubeva, Olga
    Thompson, Jenni
    Yager, Kelly
    Ilyas, Can
    Rapoport, Aaron P.
    Fenton, Robert G.
    Akpek, Gorgun
    Yanovich, Saul
    Sausville, Edward
    BLOOD, 2006, 108 (11) : 1008A - 1008A
  • [24] Successful bone reconstruction after bortezomib therapy in a myeloma patient
    Tanaka, Takayuki
    Yamasaki, Ryoko
    Omura, Hiromi
    Hino, Norihiko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (03) : 221 - 221
  • [25] Successful bone reconstruction after bortezomib therapy in a myeloma patient
    Takayuki Tanaka
    Ryoko Yamasaki
    Hiromi Omura
    Norihiko Hino
    International Journal of Hematology, 2011, 94 : 221 - 221
  • [26] Guillain-Barre syndrome in a patient with multiple myeloma after bortezomib therapy: A case report
    Xu, Yu-Ling
    Zhao, Wei-Hua
    Tang, Zhong-Yuan
    Li, Zhong-Qing
    Long, Yuan
    Cheng, Peng
    Luo, Jun
    WORLD JOURNAL OF CLINICAL CASES, 2019, 7 (18) : 2905 - 2909
  • [27] Severe Heart Failure after Bortezomib Treatment in a Patient with Multiple Myeloma: A Case Report and Review of the Literature
    Bockorny, Margarita
    Chakravarty, Saneka
    Schulman, Peter
    Bockorny, Bruno
    Bona, Robert
    ACTA HAEMATOLOGICA, 2012, 128 (04) : 244 - 247
  • [28] Lenalidomide, Bortezomib, and Dexamethasone (RVD) As Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)
    Joseph, Nisha
    Almaula, Dhwani
    Gleason, Charise
    Heffner, Leonard
    Boise, Lawrence H.
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay
    BLOOD, 2017, 130
  • [29] Bortezomib and Vorinostat Therapy as Maintenance Therapy after Autologous Transplant for Multiple Myeloma
    Holmberg, Leona A.
    Green, Damian
    Libby, Edward
    Becker, P. S.
    ACTA HAEMATOLOGICA, 2020, 143 (02) : 146 - 154
  • [30] Thrombotic microangiopathy after treatment with bortezomib and dexamethasone in a patient with multiple myeloma
    Morita, Rena
    Hashino, Satoshi
    Shirai, Shinichi
    Fujita, Noriaki
    Onozawa, Masahiro
    Kahata, Kaoru
    Kondo, Takeshi
    Imamura, Masahiro
    Asaka, Masahiro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2008, 88 (02) : 248 - 250
12345